Week 573 Review - Pretty flat - ISA up, but SIPP down more.

A pretty flat week, but ended up in the red, with the deficit between cost and value expanding by £357 to £157,066 and the deficit between injection and value increasing to £67,253. Total portfolio value fell to £120,685.

I was on holiday and was able to take weekly snapshots, but can't remember why anything happened so the next bit will be brief.

Worst performer was POLR:Polar Capital, which dropped a huge 13%. It may have gone ex-dividend as one was paid recently.

AMP:Ampeak Energy dropped 12% and IES:Invinity Energy dropped 7%.

THX:Thor Explorations dropped 7% and GGP:Greatland Resources dropped 5% as the gold miners were mostly flat.

RSW:Renishaw went down 5%.

FOUR:4imprint climbed 5% and went 1% into potential profit.

III:3i Group also went up 5% but is still 6% down.

KNOS:Kainos Group climbed 6% and is now up by 12%.

AMRQ:Amaroq defied the other gold miners and climbed 9% to go 12% up in my ISA.

W7L:Warpaint London remains volatile and went up 11% but my holding is still 14% down.

Share of the Week was DXRX:Diaceutics which zoomed up 12% but is still 16% down.

Here's the ISA and shares portfolio after week 1 of year 12.

			Weekly Change
Cash	£98.44		+£0
Portfolio cost	£113,855.00		+£0
Portfolio sell value (bid price-commission)	£30,148.69	(-73.5%)	+£215.45
Potential profits	£454.56		+£174.04
Yr 12 Dividends	£0		+£0
Yr 12 Interest	£0		+£0
Yr 12 Profit from sales	£0		+£0
Yr 12 proj avg monthly profit	£0	(0.0%)	+£0
Total Dividends	£12,574.90		+£0
Total Interest	£10.39		+£0
Total Profit from sales	£15,798.12		+£0
Average monthly cash profit	£209.66	(2.9%)	-£0.37
(Sold stocks profit + Dividends - Fees / Months)

Small increases in value and potential profit.

Just above the trend line

The SIPP looks like this after week 557 overall and week 37 of year 11.

			Weekly Change
Cash	£454.76		+£41.66
Portfolio cost	£163,385.47		+£0
Portfolio sell value (bid price - commission)	£90,025.75	(-44.9%)	-£572.51
Potential profits	£8,927.94		-£697.87
Yr 11 Dividends	£1.665.30		+£41.66
Yr 11 Interest	£15.48		+£0
Yr 11 Profit from sales	£9,419.73		+£0
Yr 11 proj avg monthly profit	£1,282.70	(15.2%)	-£30.61
Total Dividends	£19,885.50		+£41.66
Total Interest	£36.18		+£0
Total Profit from sales	£34,086.24		+£0
Average monthly cash profit	£406.40	(4.8%)	-£0.41

I got a £20 dividend from BPCR:BioPharma Credit and also £20 from BPM:BP Marsh & Partners. Portfolio value dropped £572 and potential profits dropped a bit more.

Still flat and well below the injection line.

Dragging the tend line downwards.

Nothing more to say as I have another 2 weeks of holiday snapshots to write.